CD38 and leukemia: In the case of the relapsing leukemia reported here, the separation of malignant cells from background lymphocytes based on CD38, CD10 and CD20 expression allowed for the immediate assignment of IG/TR markers to malignant cells, both at diagnosis and at relapse.